Finance

Lists
CAH:NYSE
Cardinal Health, Inc
239,08 US$
+0,42%
(+1,00) 1D
13 ოქტ, 14:24:44 GMT-4  ·   USD
All symbols
SymbolPriceChange% Change
Generating top insights for CAH...
Open
240,78 US$
High
241,18 US$
Low
236,19 US$
Mkt. cap
55,36 მლრდ.
Avg. vol.
1,72 მლნ.
Volume
695,77 ათ.
Dividend
0,86%
Quarterly dividend
0,52 US$
Ex-dividend date
1 ოქტ. 2026
P/E ratio
33,06
52-wk high
258,30 US$
52-wk low
151,87 US$
EPS
7,23 US$
Beta
0,50
Shares outstanding
231,56 მლნ.
No. of employees
61 ათ.
Open
240,78 US$
High
241,18 US$
Low
236,19 US$
Mkt. cap
55,36 მლრდ.
Avg. vol.
1,72 მლნ.
Volume
695,77 ათ.
Dividend
0,86%
Quarterly dividend
0,52 US$
Ex-dividend date
1 ოქტ. 2026
P/E ratio
33,06
52-wk high
258,30 US$
52-wk low
151,87 US$
EPS
7,23 US$
Beta
0,50
Shares outstanding
231,56 მლნ.
No. of employees
61 ათ.
News stories
From web sources and news partners
Zacks
Zacks
·
4 საათის წინ
Should Value Investors Buy Cardinal Health (CAH) Stock?
Profile
Cardinal Health Technologies, LLC doing business as Cardinal Health, is an American multinational health care services company, and the 15th highest revenue generating company in the United States. Headquartered in Dublin, Ohio, the company specializes in the distribution of pharmaceuticals and medical products, serving more than 100,000 locations. The company also manufactures medical and surgical product, including gloves, surgical apparel, and fluid management products. In addition, it operates one of the largest networks of radiopharmacies in the U.S. Cardinal Health provides medical products to over 75 percent of hospitals in the United States. Wikipedia
About Cardinal Health, Inc
CEOჯეისონ ჰოლარ
Employees61,3 ათ.
Founded1971
HeadquartersDublin, ოჰაიო, ამერიკის შეერთებული შტატები
SectorHealth care provider
Analyst ratings
Based on 14 analysts giving stock ratings to CAH in the past 3 months
Strong buy
Buy
12
Hold
2
Sell
0
12-month forecast
Based on 14 Wall Street analysts offering 12 month price targets for CAH in the last 3 months.
Highest
Current 239,08 US$
292,00 US$ (+22,13%)
Average
270,00 US$ (+12,93%)
Lowest
250,00 US$ (+4,57%)
Analyst
Recommendation
Action
Price target
Projected
Date
Ryan Halsted
RBC Capital
Buy
Maintained
276,00 US$
+15,4%
10/12/2026
Stephen Baxter
Wells Fargo
Buy
Maintained
277,00 US$
+15,9%
09/09/2026
Glen Santangelo
Barclays
Buy
Reiterated
275,00 US$
+15%
08/18/2026
Lisa Gill
J.P. Morgan
Hold
Maintained
260,00 US$
+8,8%
08/17/2026
George Hill
Deutsche Bank
Hold
Maintained
261,00 US$
+9,2%
08/13/2026
Steven Valiquette
Mizuho Securities
Buy
Maintained
250,00 US$
+4,6%
08/13/2026
Charles Rhyee
TD Cowen
Buy
Reiterated
280,00 US$
+17,1%
08/13/2026
Elizabeth Anderson CFA
Evercore ISI
Buy
Maintained
270,00 US$
+12,9%
08/12/2026
Erin Wright
Morgan Stanley
Buy
Maintained
255,00 US$
+6,7%
08/12/2026
Daniel Grosslight
Citi
Buy
Maintained
280,00 US$
+17,1%
08/12/2026
Unknown Analyst
Wells Fargo
Buy
Reiterated
277,00 US$
+15,9%
08/12/2026
Michael Cherny
Leerink Partners
Buy
Maintained
292,00 US$
+22,1%
08/11/2026
Ryan Daniels
William Blair
Buy
Reiterated
-
-
08/11/2026
Allen Lutz
Bank of America Securities
Buy
Maintained
260,00 US$
+8,8%
07/20/2026
Kevin Caliendo
UBS
Buy
Reiterated
274,00 US$
+14,6%
07/20/2026
Unknown Analyst
William O'Neil
Buy
Initiated
-
-
06/12/2026
Unknown Analyst
Argus Research
Buy
Maintained
248,00 US$
+3,7%
05/05/2026
Steven Silver
Argus Research
Buy
Maintained
248,00 US$
+3,7%
05/05/2026
Eric Coldwell
Robert W. Baird
Buy
Maintained
248,00 US$
+3,7%
05/01/2026
Max Smock
William Blair
Buy
Initiated
-
-
04/28/2026
Last report
11 აგვ. 2026
Fiscal period
Q4 2026
2,60 US$ / 2,42 US$
+7,41%beat
Revenue / Est. (USD)
63,67 მლრდ. / 65,11 მლრდ.
-2,20%miss
Fiscal Q4 2026 earnings call
Waiting for the earnings call
At a glance
Insights from the latest news and reports
Previous reportsAll values in USD
Loading Previous Earnings...
Revenue
Net income
All values in USD
სექ. 2025
დეკ. 2025
მარ. 2026
ივნ. 2026
Revenue
64,01 მლრდ.
65,63 მლრდ.
60,94 მლრდ.
63,67 მლრდ.
Cost of goods sold
61,69 მლრდ.
63,23 მლრდ.
58,44 მლრდ.
61,11 მლრდ.
Cost of revenue
61,69 მლრდ.
63,23 მლრდ.
58,44 მლრდ.
61,11 მლრდ.
Research and development expenses
-
-
-
-
Total research and development expenses
-
-
-
-
Selling, general, and admin expenses
1,46 მლრდ.
1,50 მლრდ.
1,54 მლრდ.
1,62 მლრდ.
Operating expense
1,55 მლრდ.
1,59 მლრდ.
1,64 მლრდ.
1,71 მლრდ.
Total operating expenses
63,24 მლრდ.
64,82 მლრდ.
60,08 მლრდ.
62,82 მლრდ.
Operating income
771,00 მლნ.
809,00 მლნ.
861,00 მლნ.
847,00 მლნ.
Other non operating income
10,00 მლნ.
11,00 მლნ.
-16,00 მლნ.
30,00 მლნ.
EBT including unusual items
598,00 მლნ.
630,00 მლნ.
392,00 მლნ.
554,00 მლნ.
EBT excluding unusual items
701,00 მლნ.
732,00 მლნ.
744,00 მლნ.
794,00 მლნ.
Income tax expense
144,00 მლნ.
159,00 მლნ.
12,00 მლნ.
154,00 მლნ.
Effective tax rate
24,08%
25,24%
3,06%
27,80%
Other operating expenses
-
-
-
-
Net income
450,00 მლნ.
467,00 მლნ.
399,00 მლნ.
398,00 მლნ.
Net profit margin
0,70%
0,71%
0,65%
0,62%
Earnings per share
2,55
2,63
3,17
2,60
Interest and investment income
-
-
-
-
Interest expense
-80,00 მლნ.
-88,00 მლნ.
-101,00 მლნ.
-103,00 მლნ.
Net interest expenses
-80,00 მლნ.
-88,00 მლნ.
-101,00 მლნ.
-103,00 მლნ.
Depreciation and amortization charges
-
-
-
-
EBITDA
1,00 მლრდ.
1,04 მლრდ.
1,11 მლრდ.
1,09 მლრდ.
Gain or loss from assets sale
-
-
-
-
Insider transactions
Insider transactions data is drawn from third-party sources. Learn more
Insider
Position
Type
Date
Shares
Amount
Page 1
AI content may include mistakes. Learn more
Google აპები